Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory of Molecular Genetics, |
RCV001257514 | SCV001434258 | likely pathogenic | Autosomal recessive polycystic kidney disease | 2020-05-12 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV002261328 | SCV002542176 | uncertain significance | not provided | 2021-10-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001257514 | SCV002933705 | uncertain significance | Autosomal recessive polycystic kidney disease | 2022-05-30 | criteria provided, single submitter | clinical testing | This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 3746 of the PKHD1 protein (p.Leu3746Pro). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with polycystic kidney disease (PMID: 33282801). ClinVar contains an entry for this variant (Variation ID: 978804). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |